Yttrium90, Ipilimumab, & Nivolumab for Uveal Melanoma With Liver Metastases
Contact site for start date.
Please contact ClinicalResearch@sutterhealth.org about Study Uveal Melanoma IIP.
View study details on ClinicalTrials.gov
Subjects, 18 y/o and older who have a histologic diagnosis of metastatic uveal melanoma and who have liver metastasis.
June 01, 2018